WAC DeSanto-Shinawi Syndrome — designated DESSH, WAC haploinsufficiency, or WW Domain Containing Adaptor with Coiled-Coil Syndrome, a rare autosomal dominant neurodevelopmental disorder caused by heterozygous loss-of-function pathogenic variants (frameshift, nonsense, splice-site, and missense variants; intragenic deletions; larger chromosomal deletions encompassing WAC) in WAC (WW domain containing adaptor with coiled-coil gene, chromosome 10p12.1; WAC encodes an adaptor protein with multiple functional domains: a WW domain that binds proline-rich motifs in partner proteins, a coiled-coil region that mediates protein-protein interactions and oligomerization, and a polyglutamine tract; WAC functions as part of the DRG1/DRG2 developmentally regulated GTP-binding protein complex and exerts its primary pathogenic mechanism through involvement in chromatin modification — WAC interacts with and stabilizes the RNF20/RNF40 ubiquitin E3 ligase complex that catalyzes monoubiquitination of histone H2B at lysine 120, designated H2Bub1, an epigenetic mark distributed across actively transcribed gene bodies and associated with RNA polymerase II elongation through nucleosomes; H2Bub1 deposition facilitates the chromatin remodeling required for efficient transcriptional elongation of developmental genes, and WAC haploinsufficiency reduces H2Bub1 levels and impairs transcriptional elongation of genes required for normal neurodevelopment; the syndrome was first comprehensively delineated by DeSanto and Shinawi, who identified WAC as the causative gene through exome sequencing of affected individuals) as the causative gene; the clinical phenotype of WAC DeSanto-Shinawi Syndrome is characterized by intellectual disability predominantly in the mild to moderate range, behavioral problems that include attention deficit hyperactivity disorder as a particularly common and clinically prominent feature, oppositional behavior, and aggressive outbursts, epilepsy affecting approximately 50% of individuals with variable seizure types including absence and focal seizures, hypotonia, feeding difficulties in infancy, obesity as a distinctive and clinically important feature with many WAC-affected individuals developing overweight or obesity during childhood requiring active weight management from early life, macrocephaly in a subset, behavioral and psychiatric comorbidities including anxiety and autism spectrum disorder features in a subset, characteristic facial features including dysplastic ears and broad forehead, and sleep disturbances — with WAC DeSanto-Shinawi Syndrome representing an important chromatin modification disorder in the epigenetic intellectual disability syndrome landscape alongside syndromes caused by variants in histone methyltransferases, acetyltransferases, and other ubiquitin pathway components.
WAC DeSanto-Shinawi Syndrome technology platforms — encompassing the molecular genetics laboratories where comprehensive neurodevelopmental gene panels including WAC, chromosomal microarray for 10p12 deletion detection, exome sequencing, and genome sequencing characterize the causative loss-of-function variant; the behavioral management and ADHD monitoring platforms — Conners Rating Scale administration tools, ADHD medication adherence tracking systems, behavioral incident diary platforms for aggressive outburst documentation, educational behavior support coordination tools — managing the ADHD and behavioral comorbidities that are the most prominent daily management challenges for many WAC-affected individuals; the obesity and metabolic monitoring platforms — weight and BMI trajectory tracking tools, dietitian coordination systems, metabolic screening management platforms, bariatric care coordination tools — managing the distinctive obesity tendency in WAC Syndrome that requires active intervention and metabolic surveillance from childhood; the epilepsy management platforms — seizure diary documentation systems, anti-epileptic drug adherence tracking tools, blood level monitoring platforms — managing the epilepsy affecting approximately half of WAC-affected individuals; and the adaptive behavior assessment tools, educational support and IEP management platforms, psychiatric comorbidity coordination systems, sleep diary monitoring tools, ophthalmology referral and appointment tracking platforms, and family support documentation systems coordinating the comprehensive multi-specialty care that WAC DeSanto-Shinawi Syndrome individuals require — must maintain availability and performance standards matched to the ADHD and behavioral management urgency, obesity surveillance requirements, and epilepsy monitoring demands of modern WAC Syndrome management. This guide explains why WAC DeSanto-Shinawi Syndrome tech platforms need dedicated monitoring, what to monitor, and how to build a monitoring strategy matched to the behavioral management urgency and metabolic surveillance requirements of contemporary WAC care.
Why WAC DeSanto-Shinawi Syndrome Tech Platforms Require Specialized Monitoring Attention
WAC DeSanto-Shinawi Syndrome management is defined by several clinically urgent platform requirements: the ADHD and behavioral management urgency — the ADHD affecting the majority of WAC individuals, combined with oppositional behavior and aggressive outbursts, requires behavioral management platform availability to maintain medication adherence records, document behavioral incidents, track Conners Rating Scale assessments, and coordinate the behavioral support strategies that are implemented across home, school, and community settings; the obesity management urgency — the distinctive and clinically important obesity tendency in WAC Syndrome requires weight and BMI tracking platform availability, dietitian coordination access, and metabolic screening record accessibility that are critical to the early intervention that prevents the metabolic complications of unchecked weight gain; the epilepsy monitoring urgency — the approximately 50% of WAC individuals with epilepsy require seizure diary platform availability and AED management records at every neurology review to guide drug adjustments; the educational support urgency — the mild-to-moderate intellectual disability and ADHD in WAC Syndrome require IEP management platform availability and learning support coordination records to maintain appropriate educational placement and individualized objectives; the psychiatric comorbidity urgency — anxiety and ASD features in a subset of WAC individuals require psychiatric review platform availability and medication adherence records; and the molecular diagnosis urgency — WAC loss-of-function identification confirms WAC DeSanto-Shinawi Syndrome, initiates the obesity monitoring protocol, triggers the ADHD assessment pathway, enables rare disease registry enrollment, and directs management toward the specific metabolic surveillance that WAC-related obesity demands.
Molecular genetic testing platforms establish WAC loss-of-function and confirm WAC Syndrome diagnosis. Gene panels, chromosomal microarray, exome, and genome sequencing distinguish WAC Syndrome from other behavioral and intellectual disability syndromes. Monitor at 1-minute intervals during laboratory hours.
Behavioral management and ADHD monitoring platforms coordinate the most prominent daily management challenge. Conners Rating Scale records, ADHD medication adherence, behavioral incident diary, and aggressive outburst documentation require platform availability across all care settings. Monitor at 1-minute intervals during clinical hours.
Obesity and metabolic monitoring platforms manage the distinctive WAC-related weight tendency. Weight and BMI tracking, dietitian coordination, fasting glucose and lipid panel records, and bariatric care coordination require clinical-hours platform availability for the active weight management intervention WAC Syndrome demands from childhood. Monitor at 1-minute intervals during clinical hours.
Epilepsy management platforms coordinate seizure monitoring for the half of WAC individuals with epilepsy. Seizure diary, AED adherence, blood level records, and drug side effect documentation require platform availability at every neurology encounter. Monitor at 1-minute intervals during clinical hours.
Adaptive behavior and educational support platforms maintain IEP and learning support continuity. Vineland assessment records, IEP objectives, and learning support coordination require scheduling platform availability. Monitor at 1-minute intervals during clinical hours.
What to Monitor on a WAC DeSanto-Shinawi Syndrome Tech Platform
Molecular Genetic Testing — WAC Loss-of-Function Characterization
Monitor neurodevelopmental gene panel and exome/genome sequencing records (WAC pathogenic variant identification — frameshift, nonsense, splice-site, or missense variant; intragenic deletion; ACMG variant classification; predicted impact on WAC protein function including WW domain integrity, RNF20/RNF40 interaction, H2Bub1 deposition, and transcriptional elongation of developmental genes; chromosomal microarray records for 10p12 deletion encompassing WAC — deletion size, additional deleted genes, dosage-sensitive gene content; trio analysis confirming de novo origin in most cases; parental carrier testing), genetic counseling records (de novo recurrence risk; ADHD and behavioral management anticipatory guidance — stimulant medication pathway; obesity monitoring initiation from early childhood — weight management program referral, dietitian referral, metabolic baseline measurement; epilepsy risk counseling — seizure awareness education, driving guidance for adolescents; ophthalmology referral for refractive error screening; rare disease registry enrollment; intellectual disability educational support initiation), and cascade and prenatal testing records at 1-minute intervals during laboratory hours. Alert immediately — WAC molecular testing platform failures during diagnostic evaluation of an 8-year-old male with mild-to-moderate intellectual disability, a clinical diagnosis of ADHD requiring stimulant medication, behavioral outbursts at school requiring behavioral support planning, early-onset obesity with BMI on the 97th percentile at age 8, and a single unprovoked absence seizure — when WAC loss-of-function identification confirms the clinical syndrome and initiates the structured metabolic surveillance, ADHD medication optimization, behavioral support planning, epilepsy monitoring, and dietitian-led weight management program that the WAC diagnosis directs.
Behavioral Management and ADHD Monitoring
Monitor Conners Rating Scale and ADHD assessment records (Conners Rating Scale — teacher and parent versions — at baseline, 4–6 weeks after medication initiation, and at 6-monthly intervals; ADHD severity documentation — inattention, hyperactivity, and impulsivity subscale scores; clinical ADHD diagnosis confirmation records; ADHD diagnostic review at annual clinical encounters), ADHD medication adherence and optimization records (methylphenidate or amphetamine prescription and dose records; adherence monitoring — medication taking records from parent and school; appetite suppression and weight monitoring on stimulant medication — CRITICAL in WAC Syndrome where appetite suppression may be temporarily beneficial but must be balanced against growth; sleep onset impact monitoring — stimulant effects on sleep initiation; dose titration records — optimizing for behavioral benefit while monitoring growth and sleep; medication holiday records during school breaks; non-stimulant alternative records — atomoxetine, guanfacine — for WAC individuals where stimulants are contraindicated or poorly tolerated), and behavioral incident diary and support records (aggressive outburst incident log — frequency, severity, trigger, antecedent, consequence; positive behavior support plan records; oppositional behavior management strategy documentation; de-escalation technique records for school and home; restraint and restrictive physical intervention records where applicable — safeguarding documentation; school exclusion records and behavioral support response; community incident records — aggression in public settings; respite care behavioral incident records) at 1-minute intervals during clinical hours. Alert immediately — behavioral management platform failures preventing the paediatric psychiatrist from accessing the Conners Rating Scale teacher scores and behavioral incident diary for a 12-year-old WAC male whose parents are reporting a marked escalation in aggressive outbursts at home and a school report of three physical assaults on classmates in the past month — when the ADHD symptom severity trend, the current methylphenidate dose and adherence record, the previous dose titration attempts, and the prior behavioral support plan documentation inform the psychiatric review's decision about whether to increase the stimulant dose, trial an add-on medication, initiate a behavioral support reassessment, or request a school placement review.
Obesity and Metabolic Monitoring
Monitor weight and BMI trajectory records (weight and height at every clinical encounter — six-monthly minimum in childhood; BMI calculation and centile plotting at every encounter; BMI trajectory documentation — centile trend over time; obesity classification — overweight ≥91st centile, obese ≥98th centile on UK90 or equivalent charts; waist circumference measurement annually from age 10; target weight and BMI centile trajectory goals established with dietitian), metabolic screening and complication surveillance records (fasting glucose and insulin records annually from age 10 — or earlier if BMI ≥98th centile; lipid panel — total cholesterol, LDL, HDL, triglycerides — annually from age 10; liver function tests for fatty liver disease screening; blood pressure at every clinical encounter — hypertension risk in childhood obesity; pubertal staging and growth velocity records — obesity accelerates puberty onset; sleep study for obstructive sleep apnoea in obese WAC individuals), dietary and weight management intervention records (dietitian assessment and consultation records; caloric intake and dietary composition assessment records; structured weight management programme records; family dietary education records; physical activity prescription records; dietary referral records for community weight management programmes; bariatric surgery assessment records for adult WAC individuals with severe obesity and metabolic complications where conservative management has failed), and anti-obesity medication records where applicable (orlistat records for eligible adolescents; GLP-1 receptor agonist records for adult WAC individuals with severe obesity; medication adherence and side effect monitoring; metabolic response documentation) at 1-minute intervals during clinical hours. Alert immediately — obesity and metabolic monitoring platform failures preventing the paediatric endocrinologist from accessing the BMI trajectory, fasting glucose, and lipid panel records for a 14-year-old WAC female attending her annual metabolic review — when the BMI trend showing a rise from the 95th to 99.6th centile over 18 months, the fasting glucose of 5.9 mmol/L (pre-diabetic range) detected at the previous review, the LDL of 3.8 mmol/L, and the waist circumference at the 98th centile all must be available to the endocrinologist to determine whether dietary and physical activity intervention has been sufficient or whether pharmacological intervention with orlistat or metformin is now indicated to prevent progression to type 2 diabetes.
Epilepsy Management
Monitor seizure diary and frequency records (seizure type — absence, focal, generalized tonic-clonic; seizure frequency per week or month; seizure duration; diurnal and nocturnal seizure pattern; EEG scheduling and result records — interictal spike-wave frequency for absence epilepsy; seizure action plan documentation for school and respite settings), anti-epileptic drug adherence and regimen records (current AED — ethosuximide, valproate, or lamotrigine for absence; carbamazepine, oxcarbazepine, or lamotrigine for focal; adherence monitoring; dose adjustment records; drug interaction monitoring — particularly interactions between AEDs and stimulant ADHD medications; drug side effect monitoring — valproate weight gain effect CRITICAL in WAC Syndrome where obesity is already a prominent feature), and AED monitoring records (valproate levels, LFTs, CBC; ethosuximide levels; sodium for oxcarbazepine; weight monitoring — mandatory for valproate in WAC Syndrome) at 1-minute intervals during clinical hours.
Adaptive Behavior Assessment and Educational Support
Monitor Vineland Adaptive Behavior Scales records (Vineland assessment at diagnosis, age 8, and age 16 minimum — communication, daily living skills, socialization, motor skills composite; adaptive behavior trajectory documentation — rate of adaptive skill acquisition; independence trajectory for self-care, community navigation, and daily living), and IEP and educational support records (IEP document — learning objectives, support hours, specialist provisions; IEP review records — objective attainment, placement appropriateness; educational psychologist assessment — cognitive profile, learning support recommendations; learning support coordinator records; transition planning — secondary education, further education, supported employment; post-school transition documentation for supported living) at 1-minute intervals during clinical hours.
Psychiatric Comorbidity and Sleep
Monitor psychiatric assessment and treatment records (anxiety assessment — anxiety severity documentation; CBT or behaviorally-adapted psychological therapy records; anxiolytic or SSRI prescription and adherence records where anxiety treatment has been initiated; ASD features assessment — autism diagnostic evaluation records where ASD is suspected; OT sensory needs assessment; psychiatric review records and medication optimization), and sleep diary and intervention records (sleep diary — sleep onset time, night waking frequency, total sleep duration; ADHD stimulant effects on sleep monitoring; sleep hygiene implementation records; melatonin prescription and dose records; obstructive sleep apnoea referral if indicated by symptoms in obese WAC individuals) at 1-minute intervals during clinical hours.
Ophthalmology
Monitor ophthalmology appointment records (annual refractive error screening records; spectacle prescription and compliance records; amblyopia screening and treatment records; visual acuity at each encounter) at 2-minute intervals during business hours.
Authentication and Clinical Identity
Monitor authentication at 1-minute intervals, 24/7. WAC DeSanto-Shinawi Syndrome management coordinates across molecular genetics, paediatric neurology, paediatric endocrinology, paediatric psychiatry, clinical psychology, behavior support, dietetics, ABA and educational psychology, ophthalmology, and rare disease registry — authentication failures block the multi-specialty team at encounters where ADHD records, weight trajectory, metabolic screening results, seizure diary, behavioral incident diary, and IEP documentation must all be accessible simultaneously.
SSL Certificates
Monitor SSL certificate expiry across all molecular testing platforms, ADHD management tools, obesity and metabolic monitoring systems, seizure diary platforms, behavioral support coordination systems, educational support platforms, and psychiatric records. Certificate errors disrupting metabolic monitoring platforms during an endocrinology review or behavioral management platforms during a behavioral crisis create direct adverse outcomes for a WAC-affected individual with obesity-related metabolic disease and behavioral management needs.
HIPAA and Rare Disease Privacy Considerations for WAC DeSanto-Shinawi Syndrome
WAC DeSanto-Shinawi Syndrome technology platforms handle molecular genetic records (WAC variant, de novo mutation, family genetic implications), ADHD and behavioral records (Conners scores, stimulant medication, behavioral incident diary, aggression documentation), obesity and metabolic records (weight trajectory, fasting glucose, lipid panel, bariatric care), anti-epileptic drug records, Vineland adaptive behavior assessment records, IEP and educational psychologist records, psychiatric treatment records, ophthalmology records, and sleep records across the WAC Syndrome lifespan.
Alerting Strategy for WAC DeSanto-Shinawi Syndrome Tech Platforms
Immediate laboratory-hours alerting for molecular genetic testing platforms: WAC loss-of-function identification — the diagnosis initiating the ADHD assessment pathway, obesity monitoring, epilepsy surveillance, and metabolic screening program.
Immediate clinical-hours alerting for behavioral management and ADHD monitoring platforms: Conners Rating Scale records, ADHD medication adherence, and behavioral incident diary — behavioral crisis management requires real-time accessible documentation.
Immediate clinical-hours alerting for obesity and metabolic monitoring platforms: Weight and BMI trajectory, fasting glucose, lipid panel, and weight management intervention records — the distinctive WAC-related obesity risk requires early and active metabolic monitoring from childhood.
Immediate clinical-hours alerting for epilepsy management platforms: Seizure diary, AED adherence, and drug monitoring records for the 50% of WAC individuals with epilepsy.
Immediate clinical-hours alerting for adaptive behavior and educational support platforms: Vineland assessment and IEP records — educational continuity depends on accessible documentation.
Immediate clinical-hours alerting for psychiatric comorbidity and sleep records: Anxiety treatment and sleep diary — characteristic comorbidities requiring active management.
Sustained-failure alert (10–15 minutes): Ophthalmology scheduling records.
30-day advance warning: SSL certificates across all platforms.
Status Page for WAC DeSanto-Shinawi Syndrome Care Team Communication
A real-time status page gives molecular genetics laboratories, paediatric neurologists, paediatric endocrinologists, paediatric psychiatrists, clinical psychologists, behavior support coordinators, dietitians, educational psychologists, learning support coordinators, ophthalmologists, rare disease registry coordinators, and family carers immediate platform visibility without requiring inbound IT support contact.
Vigilmon Setup for WAC DeSanto-Shinawi Syndrome Tech Platforms
| Monitor | Check Interval | Alert Channel | |---------|----------------|---------------| | Authentication | 1 min | Slack + PagerDuty (24/7) | | WAC molecular testing and variant characterization | 1 min | Slack + PagerDuty (lab hours) | | Genetic counseling and registry enrollment | 1 min | Slack + PagerDuty (lab hours) | | Conners Rating Scale and ADHD assessment records | 1 min | Slack + PagerDuty (clinical hours) | | ADHD medication adherence and dose titration | 1 min | Slack + PagerDuty (clinical hours) | | Behavioral incident diary and aggression log | 1 min | Slack + PagerDuty (clinical hours) | | Positive behavior support plan records | 1 min | Slack + PagerDuty (clinical hours) | | Weight and BMI trajectory monitoring | 1 min | Slack + PagerDuty (clinical hours) | | Metabolic screening — fasting glucose and lipid panel | 1 min | Slack + PagerDuty (clinical hours) | | Dietitian and weight management programme records | 1 min | Slack + PagerDuty (clinical hours) | | Seizure diary and frequency tracking | 1 min | Slack + PagerDuty (clinical hours) | | Anti-epileptic drug adherence and monitoring | 1 min | Slack + PagerDuty (clinical hours) | | Vineland adaptive behavior and IEP records | 1 min | Slack + PagerDuty (clinical hours) | | Psychiatric assessment and anxiety treatment records | 1 min | Slack + PagerDuty (clinical hours) | | Sleep diary and sleep intervention records | 1 min | Slack + PagerDuty (clinical hours) | | Ophthalmology appointment and vision records | 2 min | Slack (business hours) | | SSL: all domains | Daily | Email (30-day warning) |
Getting started:
- Create a free account at vigilmon.online
- Add authentication endpoints at 1-minute intervals with 24/7 alerting
- Configure WAC molecular testing platforms with immediate laboratory-hours alerting
- Add Conners Rating Scale and ADHD assessment records with immediate clinical-hours alerting
- Configure ADHD medication adherence and dose titration records with immediate clinical-hours alerting — ADHD medication optimization is a central and ongoing management requirement in WAC Syndrome
- Add behavioral incident diary and positive behavior support plan with immediate clinical-hours alerting — behavioral crisis management across home, school, and community settings requires accessible real-time documentation
- Configure weight and BMI trajectory monitoring with immediate clinical-hours alerting — CRITICAL: WAC-related obesity tendency requires weight records at every encounter from early childhood
- Add metabolic screening records with immediate clinical-hours alerting — fasting glucose and lipid panel results drive the diabetes prevention intervention that is a critical WAC Syndrome management requirement
- Configure dietitian and weight management programme records with immediate clinical-hours alerting — WAC obesity intervention requires coordinated dietitian, endocrinology, and family care team access to weight management documentation
- Add seizure diary and frequency tracking with immediate clinical-hours alerting
- Configure AED adherence and monitoring records with immediate clinical-hours alerting — note valproate weight gain effect must be flagged in WAC Syndrome where obesity is a prominent feature
- Add Vineland adaptive behavior and IEP records with immediate clinical-hours alerting
- Configure psychiatric assessment and anxiety treatment records with immediate clinical-hours alerting
- Add sleep diary and sleep intervention records with immediate clinical-hours alerting
- Configure ophthalmology scheduling with sustained-failure alerting
- Enable SSL certificate monitoring across all platforms
- Add the status page URL to WAC neurology downtime protocols, behavioral crisis procedures, metabolic emergency pathways, and multi-disciplinary care coordination workflows
Conclusion
WAC DeSanto-Shinawi Syndrome technology platforms are embedded in clinical decisions where obesity and metabolic monitoring platform availability at the annual endocrinology review — when the paediatric endocrinologist must access the BMI centile trajectory showing a rise from the 95th to 99.6th centile over 18 months, the fasting glucose of 5.9 mmol/L in the pre-diabetic range from the review six months earlier, the LDL of 3.8 mmol/L, and the dietitian-documented dietary assessment showing that caloric restriction alone has failed to arrest weight gain in this 14-year-old WAC female to make the evidence-based decision to initiate metformin for insulin sensitization, refer for structured weight management, and arrange repeat fasting glucose in three months to monitor for progression to frank diabetes — cannot be disrupted by metabolic platform failures that withhold the trajectory data whose absence means the endocrinologist cannot confirm that the pre-diabetic glucose of six months ago is a trend requiring pharmacological intervention rather than an isolated measurement, delaying a treatment decision whose six-month postponement converts a reversible pre-diabetic state into established type 2 diabetes in an adolescent whose chromatin modification disorder will predispose her to metabolic complications across a lifetime; where behavioral management platform availability during a school behavioral crisis — when the behavior support coordinator must access the positive behavior support plan, the ADHD medication dose and last Conners Rating Scale score, and the behavioral incident diary showing the trigger pattern for the aggressive outbursts in a 12-year-old WAC male to provide the school with immediate guidance that de-escalates the physical confrontation, avoids a school exclusion, and determines whether the behavioral escalation reflects under-treated ADHD requiring an urgent psychiatric medication review or a behavioral trigger amenable to environmental modification in the classroom — cannot be disrupted by behavioral coordination platform failures that leave the school without clinical guidance during a behavioral emergency whose resolution depends on accessible behavioral history, medication records, and evidence-based intervention plan; and where ADHD medication monitoring platform availability during a psychiatric review — when the paediatric psychiatrist must access the Conners Rating Scale teacher and parent scores over the past year, the current methylphenidate dose and adherence record, the appetite and weight monitoring documentation, and the sleep onset diary to determine whether the current ADHD medication is effectively managing inattention and hyperactivity while monitoring for weight suppression in a child where stimulant-related appetite reduction intersects with the WAC Syndrome obesity tendency in a clinically complex way — cannot be disrupted by ADHD management platform failures that withhold the longitudinal medication response data whose absence means the review cannot achieve its objective of optimizing the behavioral management that is the most important modifiable determinant of educational and community participation in WAC Syndrome.
Uptime monitoring gives WAC DeSanto-Shinawi Syndrome tech teams the detection capability to identify failures within seconds, trigger immediate clinical downtime procedures, and demonstrate to molecular genetics laboratories, paediatric neurologists, paediatric endocrinologists, paediatric psychiatrists, behavior support coordinators, dietitians, educational psychologists, learning support coordinators, ophthalmologists, rare disease registry coordinators, and compliance auditors that platform operational reliability matches the ADHD and behavioral management urgency, obesity and metabolic surveillance requirements, epilepsy monitoring demands, and lifelong educational and psychiatric support coordination needs of modern WAC DeSanto-Shinawi Syndrome management.
Start monitoring your WAC DeSanto-Shinawi Syndrome care tech platform for free at vigilmon.online — HTTP/HTTPS monitoring, multi-region consensus alerting, SSL certificate monitoring, automatic status page, Slack and webhook alerts. No agent required. No credit card.
Tags: #monitoring #WAC #DeSantoShinawi #DESSH #haploinsufficiency #chromatinmodification #H2Bub1 #RNF20 #ubiquitin #neurodevelopmental #intellectualdisability #ADHD #behavioral #obesity #metabolic #diabetes #epilepsy #anxiety #IEP #vineland #ophthalmology #raredisease #registry #HIPAA #healthtech #digitalhealth #uptime #sre